| 12139551 |
Anti-IDO antibody and uses thereof |
Anan Chuntharapai, Paul Blaine Mesko, Thomas E. Spires, Jr., Gaby A. Terracina |
2024-11-12 |
| 11466092 |
Antibodies against OX-40 and uses thereof |
Zhehong CAI, Indrani Chakraborty, Marie-Michelle Navarro GARCIA, Thomas D. Kempe, Alan J. Korman +12 more |
2022-10-11 |
| 11408889 |
Anti-GITR antibodies for cancer diagnostics |
Olufemi A. Adelakun, Anne C. Lewin, Alan J. Korman, Mark J. Selby, Changyu Wang +10 more |
2022-08-09 |
| 10690674 |
Anti-GITR antibodies for cancer diagnostics |
Olufemi A. Adelakun, Anne C. Lewin, Alan J. Korman, Mark J. Selby, Changyu Wang +10 more |
2020-06-23 |
| 10683357 |
Antibodies against OX40 and uses thereof |
Zhehong CAI, Indrani Chakraborty, Marie-Michelle Navarro GARCIA, Thomas D. Kempe, Alan J. Korman +12 more |
2020-06-16 |
| 10604575 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2020-03-31 |
| 10584170 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2020-03-10 |
| 10577423 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2020-03-03 |
| 10323092 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-06-18 |
| 10323093 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-06-18 |
| 10316090 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-06-11 |
| 10316091 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-06-11 |
| 10308714 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-06-04 |
| 10266596 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-04-23 |
| 10266594 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-04-23 |
| 10266595 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2019-04-23 |
| 10138299 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2018-11-27 |
| 10072082 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2018-09-11 |
| 9856320 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Jon M. Wigginton |
2018-01-02 |
| 9644032 |
Antibodies against OX40 and uses thereof |
Zhehong CAI, Indrani Chakraborty, Marie-Michelle Navarro GARCIA, Thomas D. Kempe, Alan J. Korman +12 more |
2017-05-09 |
| 9212224 |
Antibodies that bind PD-L1 and uses thereof |
John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, John M. Wigginton |
2015-12-15 |